Skip To Main Content
George Xu on Muck Rack

George Xu

As seen in: Nature, The Seattle Times, HubPages, medRxiv, The Journal of Clinical Investigation, JAAD Case Reports

Get in touch with George

Contact George, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

George Xu’s Biography

Read Full Bio →

Articles

An integrated single-cell and spatial transcriptomic atlas of thyroid cancer progression identifies prognostic fibroblast subpopulations

|
By JCI Insight, Matthew A. Loberg, George Xu, Sheau-Chiann Chen
| The Journal of Clinical Investigation
Abstract Although well-differentiated thyroid carcinoma (WDTC) is characterized by a robust treatment response, aggressive subtypes, such as anaplastic thyroid carcinoma (ATC), remain highly lethal.
Open in Who Shared Issue with article?

Mid-Autumn Pua Tiong Chiu 2025

|
By George Xu
| HubPages
Cherry Blossom with moon Friends travel and head to Luk Foo, And new acquaintances too. Despite the cold and grey weather, Everyone is happy to be together. A dinner and a dice game Is the reason they all came; With food and prizes galore, With stories and many more. It’s nice to see you come this way, And thus we all want to say: Gratitude to you and a high-five For joing us for PTC 2025! © 2025 George Xu
Open in Who Shared Issue with article?

Specificity of a polygenic score for aggressive prostate cancer

|
By Anna M. Dornisch, George Xu, Roshan Karunamuni, Charles A. Brunette
| medRxiv
AMD reports honoraria from Conquer Cancer. JAL reports grants from Alnylam Pharmaceuticals, Inc., Astellas Pharma, Inc., AstraZeneca Pharmaceuticals LP, Biodesix, Inc, Celgene Corporation, Cerner Enviza, GSK PLC, IQVIA Inc., Janssen Pharmaceuticals, Inc., Novartis International AG, Parexel International Corporation through the University of Utah or Western Institute for Veteran Research outside the submitted work.
Open in Who Shared Issue with article?
See all 7 licensed articles (8 Total)